Abstract
Purpose
Cancer survivors may experience physical, social, and emotional effects of cancer and its treatments. National Comprehensive Cancer Network (NCCN) guidelines recommend the development of a survivorship care plan (SCP) for cancer patients following completion of treatment with curative intent. Our institution developed a lymphoma survivorship clinic (SC) to assess patient needs, provide education, and create and deliver SCPs. This study analyzed the impact of a SC visit on patient-centered outcomes.
Methods
Surveys were sent to lymphoma patients at Mayo Clinic Rochester within 4 weeks of their post-treatment visit to the SC that queried patient-reported outcomes, including experience of care, quality of life (QOL), and distress. We compared survey responses between those who attended the SC and those who were eligible but did not attend.
Results
From November 2013 to May 2015, 236 lymphoma patients were surveyed, 96 of whom had a SC visit and 140 of who were eligible but did not attend. Those who attended the SC were more likely to “definitely” recall discussion on improving health, preventing illness, and making changes in habits/lifestyle, diet, and exercise. There were no differences in QOL or distress. Adjusted analyses revealed that SC attendance was associated with better self-reported overall health among younger patients and better physical well-being in Hodgkin lymphoma patients compared to those with other subtypes of lymphoma.
Conclusions
Participation in the lymphoma SC improved patient education on survivorship issues, particularly health behaviors. There may be a particular benefit in younger patients. However, there were no differences in QOL or distress. Further study is needed to determine if improved survivorship education and SCP delivery leads to long-term health benefits in cancer survivors.
Implications for Cancer Survivors
Our study evaluates the clinical impact of a SC in patients treated for lymphoma. We demonstrate that a SC visit improves patient education regarding health behaviors.
Similar content being viewed by others
References
Miller K, Siegel R, Lin C, Mariotto A, Kramer J, Rowland J, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–89.
Cutshall S, Cha S, Ness S, Stan D, Christensen S, Bhagra A, et al. Symptom burden and integrative medicine in cancer survivorship. Support Care Cancer. 2015;23(10):2989–94.
Snyder C, Frick K, Peairs K, Kantsiper M, Herbert R, Blackford A, et al. Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med. 2009;24(4):469–74.
Snyder C, Frick K, Kantsiper M, Peairs K, Herbert R, Blackford A, et al. Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol. 2009;27(7):1054–61.
Shulman L, Jacobs L, Greenfield S, Jones B, McCabe M, Syrjala K, et al. Cancer care and cancer survivorship care in the United States: will we be able to care for these patients in the future? J Oncol Pract. 2009;5(3):119–23.
Institute of Medicine and National Research Council. From cancer patient to cancer survivor: lost in transition. Washington, DC: The National Academies Press; 2006.
National Comprehensive Cancer Network. Survivorship (Version 1.2017). https://www.nccn.org/professionals/physician_gls/pdf/survivorship.pdf.
Brennan M, Gormally J, Butow P, Boyle F, Spillane A. Survivorship care plans in cancer: a systematic review of care plan outcomes. Br J Cancer. 2014;111(10):1899–908.
Boekhout A, Maunsell E, Pond G, Julian J, Coyle D, Levine M, et al. A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trial. J Cancer Surviv. 2015;9(4):683–91.
Emery J, Jefford M, King M, Hayne D, Martin A, Doorey J, et al. ProCare trial: a phase II randomized controlled trial of shared care for follow-up of men with prostate cancer. BJU Int. 2016;119(3):381–9.
Maly R, Liang L, Liu Y, Griggs J, Ganz P. Randomized controlled trial of survivorship care plans among low-income, predominantly Latina breast cancer survivors. J Clin Oncol. 2017;35(16):1814–21.
Mayer D, Birken S, Check D, Chen R. Summing it up: an integrative review of studies of cancer survivorship care plans (2006-2013). Cancer. 2014;121(7):978–96.
Birken S, Mayer D, Weiner B. Survivorship care plans: prevalence and barriers to use. J Cancer Educ. 2013;28(2):290–6.
Salz T, Oeffinger K, McCabe M, Layne T, Bach P. Survivorship care plans in research and practice. CA Cancer J Clin. 2012;62(2):101–17.
Forsythe LP, Parry C, Alfano CM, Kent EE, Leach CR, Haggstrom DA, et al. Use of survivorship care plans in the United States: associations with survivorship care. J Natl Cancer Inst. 2013;105:1579–87.
Zheng D, Sint K, Mitchell H, Kadan-Lottick N. Patterns and predictors of survivorship clinic attendance in a population-based sample of pediatric and young adult childhood cancer survivors. J Cancer Surviv. 2015;10(3):505–13.
Ou J, Smits-Seemann R, Wu Y, Wright J, Kirchhoff A. An investigation of survivorship clinic attendance among childhood cancer survivors living in a five-state rural region. J Cancer Surviv. 2017;12(2):196–205.
Arora N, Reeve B, Hays R, Clauser S, Oakley-Girvan I. Assessment of quality of cancer-related follow-up care from the cancer survivor’s perspective. J Clin Oncol. 2011;29(10):1280–9.
Hays R, Bjorner J, Revicki D, Spritzer K, Cella D. Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res. 2009;18(7):873–80.
Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med. 1979;41(3):209–18.
Birken S, Urquhart R, Munoz-Plaza C, Zizzi A, Haines E, Stover A, et al. Survivorship care plans: are randomized controlled trials assessing outcomes that are relevant to stakeholders? J Cancer Surviv. 2018;12(4):495–508.
Parry C, Kent E, Forsythe L, Alfano C, Rowland J. Can’t see the forest for the care plan: a call to revisit the context of care planning. J Clin Oncol. 2013;31(21):2651–3.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The project received IRB approval.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Viscuse, P., Yost, K.J., Jenkins, S. et al. Impact of lymphoma survivorship clinic visit on patient-centered outcomes. J Cancer Surviv 13, 344–352 (2019). https://doi.org/10.1007/s11764-019-00756-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11764-019-00756-y